01 July 2021 | News
Zimmer Biomet Holdings partners with OSSIS to cater to innovative technology and patient-specific solutions
Photo Credit: Zimmer Biomet
US-based Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced a partnership with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints.
OSSIS, a New Zealand (NZ) based company, specializes in complex hip replacements including second-time hip replacement, and replacement involving bone tumours and trauma.
"This partnership will allow Zimmer Biomet to provide our extensive network of orthopaedic surgeons with the option of patient-specific implants which are crafted with a combination of clinical and engineering expertise," said Sang Yi, Zimmer Biomet Asia Pacific Group President. "This will further strengthen Zimmer Biomet's extensive portfolio of revision hip solutions and complementary technologies, with the ultimate goal of providing innovative solutions for complex cases and improving the quality of life of patients."
"The partnership with Zimmer Biomet will enhance OSSIS' ability to support surgeons and patients alike and create a network across the Asia Pacific region of cutting-edge technology and expert capability," said OSSIS Managing Director, Kelvin Hyland.